Zacks Research Cuts Earnings Estimates for Tenet Healthcare

Key Points

• Zacks Research lowered its Q4 2027 EPS estimate for Tenet Healthcare to $5.12 from $5.13 and maintained a “Hold” rating. The consensus full-year EPS estimate is $21.04.
• Tenet recently reported strong quarterly results, with EPS of $6.12 versus the $4.26 analyst consensus and revenue of $6.04 billion, up 6.8% year over year.
• Analyst sentiment remains broadly positive, with 18 Buy ratings and three Holds, producing a “Moderate Buy” consensus and an average price target of $278.45. Institutional investors own 95.44% of the company, while insiders have sold shares recently.

Tenet Healthcare Corporation (NYSE:THC - Free Report) - Equities researchers at Zacks Research dropped their Q4 2027 earnings per share estimates for Tenet Healthcare in a research note issued on Friday, October 16th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $5.12 for the quarter, down from their previous estimate of $5.13. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for Tenet Healthcare's current full-year earnings is $21.04 per share.

Several other research analysts have also recently weighed in on the stock. Morgan Stanley boosted their price target on shares of Tenet Healthcare from $254.00 to $274.00 and gave the company an "overweight" rating in a research report on Monday, July 27th. Royal Bank Of Canada upped their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an "outperform" rating in a report on Monday, July 27th. Barclays raised their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an "overweight" rating in a research report on Friday, July 24th. UBS Group lifted their target price on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a "buy" rating in a research note on Monday, July 27th. Finally, Robert W. Baird boosted their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a "neutral" rating in a report on Tuesday, July 28th. Eighteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $278.45.

Tenet Healthcare Stock Up 0.0%

Shares of THC opened at $267.27 on Monday. Tenet Healthcare has a 52-week low of $157.58 and a 52-week high of $283.05. The company has a market capitalization of $21.52 billion, a PE ratio of 10.31, a price-to-earnings-growth ratio of 1.02 and a beta of 1.20. The stock has a fifty day simple moving average of $264.36 and a two-hundred day simple moving average of $219.29. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts' consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%. The firm's revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Manning & Napier Advisors LLC purchased a new stake in shares of Tenet Healthcare in the 2nd quarter valued at approximately $168,761,000. Arrowstreet Capital Limited Partnership boosted its position in shares of Tenet Healthcare by 57.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company's stock worth $126,757,000 after purchasing an additional 244,901 shares during the period. Bank of New York Mellon Corp acquired a new stake in Tenet Healthcare in the 2nd quarter valued at approximately $106,342,000. Empowered Funds LLC increased its holdings in Tenet Healthcare by 22.1% in the 1st quarter. Empowered Funds LLC now owns 284,753 shares of the company's stock valued at $53,736,000 after purchasing an additional 51,549 shares during the last quarter. Finally, Hsbc Holdings PLC raised its position in Tenet Healthcare by 3,478.7% in the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company's stock valued at $53,269,000 after purchasing an additional 258,956 shares during the period. Institutional investors and hedge funds own 95.44% of the company's stock.

Insider Activity at Tenet Healthcare

In other news, Director Richard J. Mark sold 10,000 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the completion of the transaction, the director directly owned 25,121 shares in the company, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Nadja West sold 1,152 shares of the firm's stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total value of $298,137.60. Following the sale, the director directly owned 23,653 shares of the company's stock, valued at $6,121,396.40. The trade was a 4.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 131,199 shares of company stock valued at $35,065,587 over the last 90 days. Corporate insiders own 0.97% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corp. NYSE: THC is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.